The melanocortin system, mapped.
Pigmentation is only the famous part. The melanocortin system runs five receptors across skin, brain and immune tissue — and the research toolkit for mapping it is smaller than you'd think.
One hormone, five receptors.
Alpha-melanocyte-stimulating hormone — α-MSH, a thirteen-amino-acid peptide clipped from a larger precursor — is best known for telling pigment cells to make melanin. But its receptor family, the melanocortin receptors MC1R through MC5R, is scattered far beyond the skin: MC1R on melanocytes governs pigmentation; MC2R answers only to ACTH and runs adrenal steroid production; MC3R and MC4R sit in brain circuits central to energy balance and appetite; MC5R is linked to exocrine function. One short hormone, five very different jobs — which is precisely what makes the system a mapping problem, and mapping problems need tools.
The tool problem: the native hormone is fragile and promiscuous.
Native α-MSH survives minutes in biological preparations and touches multiple receptors, which makes it a blunt instrument for asking which receptor does what. The research toolkit answers with engineered variants along two axes: stability (resist the enzymes) and selectivity (hit one receptor, or deliberately hit them all). The three melanocortin-lineage compounds in our catalog are textbook examples of the three useful answers.
| Compound | Structure | Receptor profile | Research role |
|---|---|---|---|
| MT-I (afamelanotide) | Linear α-MSH with two stabilizing substitutions | MC1R-focused | The selective probe — pigmentation and photoprotection biology, effects attributable to MC1R |
| MT-II | α-MSH core locked into a lactam ring | Pan-agonist: MC1R, MC3R, MC4R, MC5R | The broad screen — receptor-subtype comparisons and family-wide activation |
| KPV | The C-terminal tripeptide of α-MSH | Essentially receptor-silent | The stripped signal — anti-inflammatory activity without melanocortin-receptor pigment signalling |
What each tool's literature covers.
MT-I's substitutions — norleucine at position 4, D-phenylalanine at 7 — make it more potent and far longer-lived than α-MSH while keeping the linear architecture and MC1R preference. Its literature is pigment biology proper: eumelanin synthesis in melanocyte culture, UV-response and photoprotection models. MT-II's ring does something subtler: cyclization locks the active shape, resisting degradation from the ends while broadening which receptors the fixed conformation fits. That breadth put it in two literatures at once — pigmentation, and the substantial preclinical record on MC3R/MC4R appetite and energy-balance circuits. And KPV is the deconstruction: the anti-inflammatory tail of the hormone with the pigment machinery left behind, studied in gut-epithelium and immune-cell models.
Why the pairing logic matters.
Run MT-I and MT-II against the same readout and the comparison itself is informative: an effect both produce likely runs through MC1R; an effect only the pan-agonist produces points at MC3R, MC4R or MC5R. Add selective antagonists and the map sharpens further. This selective-plus-broad pairing is the standard receptor-mapping design, and it's the reason our melanocortin line is built as a matched pair with batch-verified purity on both sides — a screening result is only as clean as the compounds doing the screening.
A structural footnote worth knowing: MT-II is also the standard classroom example of what cyclization does to a peptide — stability, potency and selectivity all shifting from one topological change. For labs studying peptide engineering itself rather than melanocortin biology, that's a second reason the molecule keeps appearing in methods sections. General handling for both is unremarkable; the storage guide covers it.
Common questions.
MT-I is a linear, MC1R-selective α-MSH analogue for pinning effects to one receptor; MT-II is a cyclic pan-agonist that activates most of the family at once for screening across it.
Yes — afamelanotide is the compound's name in the scientific literature ([Nle4, D-Phe7]-α-MSH). MT-I is the research-supply shorthand.
By lineage: it's the C-terminal fragment of α-MSH itself. Its scientific value is exactly that it retains the parent's anti-inflammatory signalling while shedding receptor-driven pigment activity — the control molecule the family's biology needed.
